دورية أكاديمية
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!
العنوان: | Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere! |
---|---|
المؤلفون: | Barac A; Clinic for Infectious and Tropical Diseases, Clinical Center of Serbia, Belgrade, Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. Electronic address: aleksandrabarac85@gmail.com., Bartoletti M; Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy., Azap O; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Başkent University, Ankara, Turkey., Bussini L; Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy., Ergonul O; Koc University Research Center for Infectious Diseases, Istanbul, Turkey., Krause R; Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Paño-Pardo JR; Fundación Instituto de Investigación Sanitaria Aragón (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), Zaragoza, Spain, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Power NR; Royal College of Physicians of Ireland, Setanta House, Setanta Pl, Dublin, Ireland., Rodríguez-Baño J; Clinical Unit of Infectious Diseases and Microbiology Virgen Macarena University Hospital and Department of Medicine, University of Seville, Institute of Biomedicine of Seville, Seville, Spain., Sibani M; Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Szabo BG; South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Budapest, Hungary, Semmelweis University, School of PhD Studies, Budapest, Hungary., Tsiodras S; Fourth Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece., Verweij PE; Department of Medical Microbiology and Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, the Netherlands., Quirós AM; Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain., Zollner-Schwetz I; Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria. |
المصدر: | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2022 Jul; Vol. 28 (7), pp. 908-910. Date of Electronic Publication: 2022 Mar 23. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691 (Electronic) Linking ISSN: 1198743X NLM ISO Abbreviation: Clin Microbiol Infect Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2015- : London : Elsevier Original Publication: Paris : Decker Europe, c1995- |
مواضيع طبية MeSH: | COVID-19 Drug Treatment*, Humans ; Ivermectin/therapeutic use ; Pandemics ; SARS-CoV-2 |
فهرسة مساهمة: | Keywords: COVID-19; Clinical; ESCMID guidelines; Ivermectin; Treatment |
المشرفين على المادة: | 70288-86-7 (Ivermectin) |
تواريخ الأحداث: | Date Created: 20220326 Date Completed: 20220622 Latest Revision: 20221207 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC8942456 |
DOI: | 10.1016/j.cmi.2022.03.022 |
PMID: | 35337977 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1469-0691 |
---|---|
DOI: | 10.1016/j.cmi.2022.03.022 |